Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CCL5 derived from tumor-associated macrophages promotes prostate cancer stem cells and metastasis via activating β-catenin/STAT3 signaling
Renlun Huang, Shengqi Wang, Neng Wang, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 4
Open Access | Times Cited: 213

Showing 1-25 of 213 citing articles:

Macrophages in immunoregulation and therapeutics
Shanze Chen, Abdullah F. U. H. Saeed, Quan Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 727
The CCL5/CCR5 Axis in Cancer Progression
Donatella Aldinucci, Cinzia Borghese, Naike Casagrande
Cancers (2020) Vol. 12, Iss. 7, pp. 1765-1765
Open Access | Times Cited: 302
CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands
Jan Korbecki, Szymon Grochans, Izabela Gutowska, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7619-7619
Open Access | Times Cited: 273
Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies
Nisha Kumari, Seung Hong Choi
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 214
Cancer Stemness Meets Immunity: From Mechanism to Therapy
Peiwen Chen, Wen‐Hao Hsu, Jincheng Han, et al.
Cell Reports (2021) Vol. 34, Iss. 1, pp. 108597-108597
Open Access | Times Cited: 180
Tumor microenvironment enriches the stemness features: the architectural event of therapy resistance and metastasis
Palanisamy Nallasamy, Rama Krishna Nimmakayala, Seema Parte, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 118
STAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy response
Mehrdokht Sadrkhanloo, Maliheh Entezari, Sima Orouei, et al.
Pharmacological Research (2022) Vol. 182, pp. 106311-106311
Closed Access | Times Cited: 110
A second-generation M1-polarized CAR macrophage with antitumor efficacy
Anhua Lei, Hua Yu, Shan Lu, et al.
Nature Immunology (2023) Vol. 25, Iss. 1, pp. 102-116
Open Access | Times Cited: 87
Exploiting innate immunity for cancer immunotherapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 78
LAG-3 and PD-1 synergize on CD8+ T cells to drive T cell exhaustion and hinder autocrine IFN-γ-dependent anti-tumor immunity
Lawrence P. Andrews, Samuel C. Butler, Jian Cui, et al.
Cell (2024) Vol. 187, Iss. 16, pp. 4355-4372.e22
Closed Access | Times Cited: 56
Hallmarks of cancer stemness
Jia-Jian Loh, Stephanie Ma
Cell stem cell (2024) Vol. 31, Iss. 5, pp. 617-639
Closed Access | Times Cited: 53
Single‐Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Esophageal Squamous Cell Carcinoma
Yongxu Jia, Baifeng Zhang, Chunyang Zhang, et al.
Advanced Science (2023) Vol. 10, Iss. 7
Open Access | Times Cited: 47
Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives
Xiaoli Shi, Xinyi Wang, Wentao Yao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 29
The crosstalk between macrophages and cancer cells potentiates pancreatic cancer cachexia
Mingyang Liu, Yu Ren, Zhijun Zhou, et al.
Cancer Cell (2024) Vol. 42, Iss. 5, pp. 885-903.e4
Open Access | Times Cited: 20
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 10
Roles of tumor-associated macrophages in tumor progression: implications on therapeutic strategies
Shuangli Zhu, Ming Yi, Yuze Wu, et al.
Experimental Hematology and Oncology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 98
Research trends in pharmacological modulation of tumor‐associated macrophages
Neng Wang, Shengqi Wang, Xuan Wang, et al.
Clinical and Translational Medicine (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 87
Progress in Natural Compounds/siRNA Co-delivery Employing Nanovehicles for Cancer Therapy
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, et al.
ACS Combinatorial Science (2020) Vol. 22, Iss. 12, pp. 669-700
Open Access | Times Cited: 84
Hypoxia Alters the Expression of CC Chemokines and CC Chemokine Receptors in a Tumor–A Literature Review
Jan Korbecki, Klaudyna Kojder, Katarzyna Barczak, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5647-5647
Open Access | Times Cited: 70
Understanding and targeting prostate cancer cell heterogeneity and plasticity
Dean G. Tang
Seminars in Cancer Biology (2021) Vol. 82, pp. 68-93
Open Access | Times Cited: 60
CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322/CCL20/CCR6 signaling
Tao Xie, Du-Jiang Fu, Zhimin Li, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 59
LC3-associated phagocytosis in bone marrow macrophages suppresses acute myeloid leukemia progression through STING activation
Jamie A Moore, Jayna J. Mistry, Charlotte Hellmich, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 5
Open Access | Times Cited: 52
Tumor-associated macrophage-derived chemokine CCL5 facilitates the progression and immunosuppressive tumor microenvironment of clear cell renal cell carcinoma
Wenhao Xu, Yuhao Wu, Wangrui Liu, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 13, pp. 4884-4900
Open Access | Times Cited: 52
Chemokines and cytokines: Axis and allies in prostate cancer pathogenesis
Mohd Mughees, Jyoti Kaushal, Gunjan Sharma, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 497-512
Open Access | Times Cited: 50
Prostate cancer immunotherapy: a review of recent advancements with novel treatment methods and efficacy.
Ian Wang, Liankun Song, Beverly Y. Wang, et al.
PubMed (2022) Vol. 10, Iss. 4, pp. 210-233
Closed Access | Times Cited: 50
Page 1 - Next Page

Scroll to top